What are the appropriate blood glucose targets for elderly nursing home residents (including fasting and post‑prandial ranges) and how should therapy be adjusted to avoid hypoglycemia?

Acceptable Blood Sugar Targets in Nursing Facilities

For elderly nursing home residents, target A1C <8.0% (fasting/premeal glucose 100-200 mg/dL) with the primary goal of avoiding hypoglycemia rather than achieving tight glycemic control, as hypoglycemia poses catastrophic risks that far outweigh any benefits of intensive glucose lowering in this population. 1, 2

Specific Glucose Targets by Resident Category

The 2025 ADA Standards stratify targets based on health status 2:

Long-Term Care Residents (Most Common)

• A1C goal: <8.0% (avoid relying heavily on A1C due to interfering conditions)
• Fasting/premeal glucose: 100-200 mg/dL (5.6-11.1 mmol/L)
• Primary objective: Avoid hypoglycemia and symptomatic hyperglycemia
• Rationale: Multiple chronic illnesses, ADL impairments, and cognitive dysfunction impair self-management and increase hypoglycemia risk 1, 2

Short-Term Rehabilitation Residents

• Glucose goal: 100-200 mg/dL
• Slightly tighter control may be warranted for wound healing and infection prevention
• Monitor closely as recovery from acute illness impairs cognitive function 2

End-of-Life/Very Complex Residents

• Avoid A1C targets entirely
• Goal: Prevent symptomatic hyperglycemia (>300 mg/dL) and any hypoglycemia
• Focus exclusively on comfort; discontinue finger sticks if causing distress 1, 2

Critical Thresholds Requiring Action

The 2016 ADA position statement provides specific protocols 1:

Hypoglycemia (<70 mg/dL):

• Single episode with symptoms: Treat immediately per protocol
• Consecutive readings <70 mg/dL: Call practitioner, confirm with lab test, increase monitoring frequency for 24 hours, adjust regimen

Hyperglycemia:

• 250 mg/dL twice in 24 hours with status change: Call practitioner, increase monitoring

• 300 mg/dL for 2 consecutive days: Confirm with lab, evaluate intake, adjust regimen

• Persistent elevation after adjustment: Evaluate for infection or other causes

Therapy Adjustment Principles

Avoid Sliding Scale Insulin as Primary Therapy

Sliding scale insulin (SSI) should not be used as the sole diabetes treatment 1. When SSI is currently being used:

• Calculate average daily insulin requirement over 5-7 days
• Convert 50-75% to scheduled basal insulin
• Use fixed-dose mealtime insulin or non-insulin agents for postprandial control
• Consider morning basal insulin dosing to reduce early-morning hypoglycemia risk 1

Medication Simplification and Deintensification

Deintensification is required when 2:

• Severe or recurrent hypoglycemia occurs (regardless of A1C level)
• Cognitive dysfunction, depression, or inconsistent eating develops while on sulfonylureas/meglitinides
• Weight loss or anorexia occurs
• Patient taking medications without clear symptom benefit

Treatment simplification needed when 2:

• Unable to manage complexity of insulin plan
• Significant change in social circumstances (loss of caregiver, financial difficulties)
• Pain or discomfort from injections/finger sticks

Medication Selection Considerations

For nursing home residents, prioritize agents with:

• Low hypoglycemia risk: Metformin preferred when tolerated
• Avoid: Sulfonylureas and meglitinides due to unpredictable hypoglycemia risk with irregular meal intake
• Insulin selection: If needed, use basal insulin (determir or glargine) over NPH; ultra-short acting prandial insulins over regular insulin 3
• GLP-1 agonists: Avoid in residents with unexplained weight loss or recurrent GI problems 2

Common Pitfalls to Avoid

Overtreatment is rampant: Research shows 17% of nursing home residents meet criteria for frank overtreatment (A1C <6.5% on insulin), yet 73% continue without deintensification 4. This represents dangerous practice.

Key errors:

• Treating isolated abnormal values rather than trends 1
• Continuing intensive regimens in residents with cognitive decline or functional impairment
• Failing to adjust therapy after hypoglycemic episodes
• Using restrictive diets that worsen nutritional intake (liberal diet plans improve outcomes) 1
• Inadequate staff training on hypoglycemia recognition and glucose trend interpretation 1

Monitoring Frequency

Base monitoring on regimen complexity and hypoglycemia risk 1:

• Complex insulin regimens: Multiple daily checks
• Stable oral agents: Less frequent monitoring acceptable
• Increase frequency: After any regimen change, during acute illness, or after hypoglycemia

Critical point: Persistent hyperglycemia increases risk of dehydration, falls, urinary incontinence, and hyperosmolar syndrome, so complete neglect of glucose control is also inappropriate 1. The goal is balanced management prioritizing safety over perfection.